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The crystal structure of human recombinant intcrlcukin.4 (IL,.4) has I:~.cn solvc,,'l by multiple isomorphous replacement, and rafin~ to an R factor 
of 0,218 at 2,2S A resolution, Tl~ mot¢cule is a left-handed four.helix bundle with a short stretch of,~ shaft, 'rl.a: structure be.ar~ olo~ r~,rnblans~ 
to other cytokines such as granuloc~tc.macropha~: colony ttimulating factor (GM,.CSF). Althouah no sequence sdmlladty of 11.-4 to GM.CSF 
and other related cytokines has be~n previ~ualy postulated, structure.based alignment of IL-4 and GM.CSF r~vealed that th¢core of the molcul~, 
including larl~ parts of all four hel i~ and ~tcnding over half of tl~: molecule, has 30% sequenco identity, This may have idcntifl~;l regions which 
arc not only important to maintain structu~, but could also play a role in r~'.~ptor binding. 
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I. INTRODUCTION 
Interlcukin-4 (IL-4) is a member of a family of cyto- 
kines including IL-2, IL-3, IL-6 and granulocyte-mac- 
rophage colony stimulating factor (GM-CSF), which 
share a similar polypcptide fold it]. IL-4 plays an im- 
portant biological role in being able to stimulate the 
proliferation and differentiation of a number of differ- 
ant cell types [2]. and it has properties which may make 
it important pharmaceutically [3]. Molecular modeling 
[4] and NMR s~ctroscopy [5,6) have shown this mole- 
cule to be a 4-helix bundle similar in its structure to 
OM-CSF  [7] and porcine [8] and human growth 
hormones [9]. Two independent atomic models in solu- 
tion have been produced based on NMR data [10,11]. 
While crystallization of 11.-4 has been previously de- 
scribed [12,13], no crystal structure has been reported. 
The present work describes solution of the crystal struc- 
ture by the method of multiple isomorphous repla~- 
meat (MIR), preliminary refinement of the structure, 
and the comparison with the structure of  GM-CSF  [7]. 
2. MATERIALS  AND METHODS 
Human recombinant IL-4 used in the initial investigations f the 
crystallization conditions was a gift of Chimtcch (Moscow, Ruuia), 
while material purchased from PrcproT¢ch (Rocky Hill, N;) was uned 
for the bulk of the work, The polypeptide of 130 amino acids was 
expressed in ~, carl, and we., stored as lyophilized powder, The N- 
terminal methionine waspr~..~nt i  approximately 70% of the sample, 
but sinc¢ it was not ~¢n in the ¢l~tron density maps (s¢¢ below), the 
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numbering used in this paper follows the native re.quanta, starling wi~ 
His.I and continuing to $¢r.129, Carom©faintly obtained material 
migrated as a single band on n polyacrylamid¢ t'~:asing 1~1, and was 
not further purified. 
Crystals of 1L-4 were grown at room t~mperatur¢ by the hanging 
drop, vapor diffusion t~hnique [14]. Droplets containing 4 mlgml 
protein in 30 mM g.phosphate buffer, pH 6,0, were ~luilibrar~d 
allainst a reservoir containing 60~Z% ammonium sulfate in the same 
buffer. Needle-like crystals aplx.argl in a wc~k and reached maximum 
size in two to thrae weeks. Heavy atom derivativc~ were prepared by 
~aking crystals in solutions containing suitable compounds. A total 
of 25 dill'croat potential hmvy atom compounds ware inv¢stillat~. 
Diffraction data were collected forthe native and derivative crystals 
using a Siemens multiwire area dct~tor mounted on a gipku RU.2{}0 
rotating anode, olxrated at S0 kV and 100 mA. Thm¢ data wcr¢ 
integrated using the XENGEN proi:am system [IS]. In addition, 
one derivative data ~t, and the native data used in the final rt, fine- 
meat, were measured with an R.AXIS lie image plate detector, ~in8 
an equivalent X-ray m,r~, and were proc~sed with the ~ftware 
provided by the manufacturer, Scaling of data sets and refinemcmt of 
the heavy atom positions and pha~ calculations wcr¢ aw.omplishcd 
with program PHASF.S [16], electron density map~ werefitted rains 
FRODO [171, and the models were refined with PROLSQ [181 and 
X-PLOR [191. 
3, RESULTS 
Crystals of IL-4 belong to the space group P4j2j2 (the 
¢nantiomorph established on the basis of the 
anomalous scattering of the heavy atoms). Unit ¢¢II 
parameters are a=b=91.8 A, e=46.4 A, with one mole- 
cule present in ,,he asymmetric unit. Derivative data 
were collected to the r~olut ion of  2.7-3.5 A (Table I), 
while the native data extended to 2.23 A and were r~a- 
sonably =omplct¢ (9,169 out o f  10.104 possible reflec- 
tions measured, with 8,223 reflections having / > 1.5 
o'(I)). 
An electron density map was computed with MIR  
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Fig. i, F~ :ctron d,'nsity corresponding to helix A (rctidues 4.-[9) contoured, at l # level, with the coordinate of tha final model superimposed, 
(A) MIR map computed at 2,? A with the pharos calculatc=d as shown in, Table= I. (B) 2F.-F~ dilTerenca Fourier map at 2.25 A rcmlution at th~ 
final staBe of refinement. 
phases from five derivatives, three of which also pro- 
vided usable anomalous  data (Table I). The map was  
rather noisy, even though the four helices could be idea. 
til~ed without ambiguity (Fig. lA), Attempts to improve 
the map by solvent flattening ware not succ, cssful, de- 
spite the high solvent content of  th~,se crystals, The 
Table I 
Summary o(cry~tallographic data collection and phasing 
Data let Unique ReJolution Completeness "Rm,~, "R=~. "-~.m, Phasing H~vy atom 
refections (A) (%) poweP 
F > 2o iso(ano) Number Location 
Native" 8951 2.23 90.7 0.06 
Trimethyl'" 4851 2.? ~.S 0.07 0.202 0.65 1.34 (1.48) I Asp-3I; Glu-114 
load ac--tate 
KzPt(NO=),' 292? 3.0 9"/.8 0,10 0.148 0.66 1.23 (1,34) l Hi=-58; His-59 
Iodine' 3156 3,0 92,3 0,10 0,140 0,65 1,28 (1,43) I Tyr-$6 
Gold sodium' 206'/ 3,2 67,7 0.11 0.150 0,~5 0.gL l Phe-t 12 
thiomalate 2 Thr.18; l.~u-113 
K:PtCl," 1934 3,5 8?,4 0.I0 0.178 0,?l 0.95 l Thr-22; Hi~-76 
2 S¢r-10?; Ars-115 
'rhc overall figure of merit i,~ 0,524 {'or S 193 independent reileetions with/;" > 2a(b") in resolution range 25-2.7 ~. Dam ¢oll~ted on: "'R-AXIS; 
"Siemens. "R,~,,j.-'2~ It.~- </>I/,~<,rS; ,,%~,, = Z i Fm~-F, I/,Z.~,; °R,.,,, = ~' II Fm± :', l - I F. I/ZI Fm l -l Fp I ', =Phasing power for iso = ~'~/~ 
ano I - l ~2FjtlE 
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Fig. 2, Stercovicw ofthe structur, of Ii.-4. Main chain is printed by ~ trace, while all side chain atoms am shown in thin lincJ. 
initial fit to this map was verified in a comparison with 
the NMR coordinates [10]. which also were useful in 
tracing some of the broken density belonging to th~ 
regions lacking regular =¢¢ondary structure, 
The initial atomic oordinates were subjected to three 
cycles of simulated annealing [19] and to least squares 
refinement [18], r~ulting in the crystallographic R fac- 
tor of 0.218 for a model consisting of all 129 amino 
acids, as well as 33 water molecules (Fig, 2). The root 
mean square (rms) deviation of bond lengths from the 
PROLSQ [18] targets is 0.020 A, individual temperature 
factors are restrained, and the Ramachandran plot is 
acceptable except for poorly defined residues 38 and 40. 
The quality of the final map is good (Fig. IB). Further 
studies at high,r resolution, and fuller dcscripxion of the 
solvent structure arc in progress. 
Crystallographic model of IL-4 did not significantly 
modify previous descriptions of the structures solved by
NMR [5,6,10,11]. The core of the molecule isformed by 
a left.handed helical bundle, consisting of helix A (resi- 
dues 4-.19), B (40-60), C (70-94), and D (109-128). The 
hclic¢s are connected by three loops forming the most 
flexible part of' th~ molecule. Two//-strands which arc 
part of the loops form a short fragment of antiparallcl 
/~-ribbon (residues 27-31 and 105-109)connected by 
four hydrogen bonds (Fig. 3). 
The core of the molecule between the helices is filled 
by residues with mostly hydrophobic character (Thr.6, 
Lcu-?, Ile-10, Ile-! 1, Thr-13, Lcu-14, Lcu-17 in helix A; 
Thr-44, Phe-45, Ala-48, Ala-49, Val-Sl, Lea-S2, Ph¢-5~ 
in helix B; Leu-79, lie-80, Phe-82, Leu-83, Leu-86, Leu. 
90, Leu-93, Ala-94 in helix C; and Leu-109, Phe.112, 
Lcu-I '.3, L,u-116, lle-119, Met-120 in helix D). This 
core is completed by the predominantly h drophobic 
residues Thr-25, Val-29, I1c-32 and Ph=.33 from th~ 
irregular part of the structure. Several charged residues 
reside inside the hydrophobic core, forming possible ion 
pairs. The side chain of Glu-41 interact= with Lya-123, 
and His-59, Asp-62 and Arg.64 are sharing an ionic 
interaction (the latter two r~idues arc located outside 
of the helices). 
A promin¢nt feature of the structure is the string of 
positively charged residues (His-74, Lys-77, Ar$-81, 
Lys-84, Arg-8$, Arg-88). All of them are exposed and 
their charges are uncomlzmsated by other residues, ex- 
cept for Lys-84 wrdch may form an ion pair with the 
side chain of Glu.60. These residues, except for Arg-BB, 
are not involved in crystal contacts. Such formation of 
a positively charged 'wall' may play a role in the interac- 
tion of IL-4 with its tempter. 
4. DISCUSSION 
Crystal structure of IL.4 bears close resemblance to 
the solution structure derived by NMR [10], with 126 
C= atoms deviatin$ by 1.65 A (mas) upon Sul~rposition. 
Residues with significant deviations (greater than 3 A) 
include the amino terminus (1-3), 36 and 37 (located in 
a poorly defined region), 63 and 68 (part of the strand 
63-70, all of which shows large deviations), 95, 100 and 
103 (in the region o['91-104 which differs ignificantly), 
12S, 126, and 129 (C terminus). All of these differen=s 
are in stretches of irregular structure outside of the 
helical regions, usually with hi$h temlz=rature factors, 
61 
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FiB. 3. $~condar~ ltructur¢ diagram of IL.4, showin8 all main c~ain ttyOro~n bonds (indicated b), arrow'O, as well as the thr~ disulfid~ bor, ds. 
and may have resulted from the influenc, of crystal 
packing, as well as from artifacts of structure determi- 
nation by ,ither method. In addition, large deviations 
are a¢~n for many side chains, including bulky ones such 
as Trp-91. These differences are considerably larger 
than those reported in a similar comparison of solution 
and NMR structures of interleukin-8 [20], but it is clear 
that the quality of both th~ X-ray and NMR structures 
of IL-4 is ~ignificantly low¢r. 
GM-CSF is th¢ other related c~tokine with publicly 
available atomic oordinates, and therefore its compar- 
ison with IL-4 is possible. Both of th~s, structures ar, 
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Fig. 4, Su~rposition of residues corresponding to heli~.'~ A an~ u, a= v,=. == u= .=cp stranos, o! 1/..4 (heavy line) and GM-CSF (l irw line), Sid~ 
chains which arc explicitly shown belong to IL-4, but are the same in GM.CSF. 
based on the motif of a left.handed, four helix bundle. 
The length of the helices and of the connecting loops 
varies between them, The pattern of disulfide bridges is 
ditTercnt between the two, with three present in IL.4 and 
only two in GM-CSF. The S-S bridge between residues 
24-65 in IL--4 has no ¢qu."valcnt in GM-CSF ,  sin= the 
helices B and C arc shorter there and the two structures 
do not superimpose in the connoting loop, The bridge 
45-99 which joins helix B and the loop CD is topologi- 
cally equivalent to 54-96 in GM-CSF .  although struc- 
turally not identical. The bridse 3-127 joins the two 
termini in IL-4 (halites A and D), while the bridge 88- 
121 in GM-CSF  attaches helix C to D, 
The lack of sequence similarity between many cytok. 
ines and growth factors which have been shown either 
experimentally or by modeling to have a common fold 
[1.7,9.10] has been repeatedly reported [5,11,21]. This 
was in marked contrast to the similarities of their recep- 
tors, which are clearly related in sequence, although 
they also share sequence similarity with receptors for 
unrelated cytokines [21], Structural alignment of IL-4 
with GM-CSF has now revc=aled that significant se- 
quence similarity does indeed exist in the structurally 
equivalent cores of the molecules, Superposition of 
about half of IL..4 mot=cult, consisting of 61 C= atoms 
in all four helios, as well as in connecting regions AB 
and CD, shows that the deviation from GM-CSF  is only 
1.5 A, while IS residues (30%) are identical, and another 
at least 9 (I 5%) are highly conserved. The segments used 
in these comparisons include residues 4-16 in IL-4 (cor- 
responding to 16-28 in GM-CSF),  22-30 (32--41, with 
35 deleted), 42-52 (56-56), 83-95 (70--82), and I06-120 
(100-114). This similarity is particularly close in the 
region of helices A and D, as well as th¢~ contact region 
25-30 and I06-I 10, where the deviation is only l ,~ 
(Fig, 4), This region may correspond to the area on the 
surface of the protein implicated in receptor binding for 
the human growth hormone [9], and may indeed show 
that certain features of the receptor binding region of 
cytokines are conserved (even though IL..4 and GM- 
CSF are not cro~s-reactiv¢ against their respective t=- 
ceptors). Once the coordinates of other cytokines be- 
come available, further comparisons will be .n~,essary. 
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